Jill M. Quigley Terns Pharmaceuticals, Inc. (TERN) insider trading activity

Jill M. Quigley is of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of TERN, which is worth approximately $0. The most recent transaction as insider was on Nov 04, 2025, when has been sold 24,520 shares (Common Stock) at a price of $18.0 per share, resulting in proceeds of $441,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Jill M. Quigley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2025	SELL Open market or private sale	$441,360 $18.0 p/Share	24,520 Reduced 100.0%	0 Common Stock
Nov 04 2025	BUY Exercise of conversion of derivative security	$226,564 $9.24 p/Share	24,520 Added 50.0%	24,520 Common Stock
Jan 06 2025	SELL Open market or private sale	$50,720 $5.79 p/Share	8,760 Reduced 100.0%	0 Common Stock
Jan 02 2025	SELL Open market or private sale	$35,692 $5.72 p/Share	6,240 Reduced 41.6%	8,760 Common Stock
Sep 09 2024	SELL Open market or private sale	$172,350 $10.0 p/Share	17,235 Reduced 53.47%	15,000 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$31,367 $1.82 p/Share	17,235 Added 34.84%	32,235 Common Stock
Aug 02 2024	SELL Open market or private sale	$66,427 $7.5 p/Share	8,857 Reduced 37.13%	15,000 Common Stock
Aug 01 2024	SELL Open market or private sale	$47,178 $7.68 p/Share	6,143 Reduced 20.48%	23,857 Common Stock
Jul 16 2024	SELL Open market or private sale	$4,000 $10.0 p/Share	400 Reduced 1.32%	30,000 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$728 $1.82 p/Share	400 Added 1.3%	30,400 Common Stock
Jul 15 2024	SELL Open market or private sale	$143,650 $10.0 p/Share	14,365 Reduced 32.38%	30,000 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	$26,144 $1.82 p/Share	14,365 Added 24.46%	44,365 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	15,000 Added 33.33%	30,000 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Common Stock

Also insider at

PASG

Passage BIO, Inc. Healthcare

Chief Operating Officer

CMMB

Chemomab Therapeutics Ltd. Healthcare

Director

JMQ

Jill M. Quigley

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Value

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Terns Pharmaceuticals, Inc.

Track Activities on TERN

Account